India · Delayed Price · Currency is INR Glenmark Pharmaceuticals Statistics
Total Valuation
NSE:GLENMARK has a market cap or net worth of INR 548.60 billion. The enterprise value is 533.94 billion.
| Market Cap | 548.60B |
| Enterprise Value | 533.94B |
Important Dates
The last earnings date was Friday, November 14, 2025.
| Earnings Date | Nov 14, 2025 |
| Ex-Dividend Date | Oct 3, 2025 |
Share Statistics
NSE:GLENMARK has 282.20 million shares outstanding. The number of shares has increased by 0.02% in one year.
| Current Share Class | 282.20M |
| Shares Outstanding | 282.20M |
| Shares Change (YoY) | +0.02% |
| Shares Change (QoQ) | -0.02% |
| Owned by Insiders (%) | 3.11% |
| Owned by Institutions (%) | 33.18% |
| Float | 141.51M |
Valuation Ratios
The trailing PE ratio is 54.33 and the forward PE ratio is 23.29. NSE:GLENMARK's PEG ratio is 1.11.
| PE Ratio | 54.33 |
| Forward PE | 23.29 |
| PS Ratio | 3.43 |
| PB Ratio | 5.73 |
| P/TBV Ratio | 7.06 |
| P/FCF Ratio | 30.69 |
| P/OCF Ratio | 19.65 |
| PEG Ratio | 1.11 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 13.29, with an EV/FCF ratio of 29.87.
| EV / Earnings | 52.87 |
| EV / Sales | 3.34 |
| EV / EBITDA | 13.29 |
| EV / EBIT | 14.73 |
| EV / FCF | 29.87 |
Financial Position
The company has a current ratio of 1.65, with a Debt / Equity ratio of 0.13.
| Current Ratio | 1.65 |
| Quick Ratio | 0.93 |
| Debt / Equity | 0.13 |
| Debt / EBITDA | 0.30 |
| Debt / FCF | 0.68 |
| Interest Coverage | 14.87 |
Financial Efficiency
Return on equity (ROE) is 11.20% and return on invested capital (ROIC) is 21.54%.
| Return on Equity (ROE) | 11.20% |
| Return on Assets (ROA) | 13.23% |
| Return on Invested Capital (ROIC) | 21.54% |
| Return on Capital Employed (ROCE) | 30.09% |
| Revenue Per Employee | 10.12M |
| Profits Per Employee | 639,139 |
| Employee Count | 15,800 |
| Asset Turnover | 0.93 |
| Inventory Turnover | 1.51 |
Taxes
In the past 12 months, NSE:GLENMARK has paid 5.17 billion in taxes.
| Income Tax | 5.17B |
| Effective Tax Rate | 33.88% |
Stock Price Statistics
The stock price has increased by +28.91% in the last 52 weeks. The beta is 0.32, so NSE:GLENMARK's price volatility has been lower than the market average.
| Beta (5Y) | 0.32 |
| 52-Week Price Change | +28.91% |
| 50-Day Moving Average | 1,913.17 |
| 200-Day Moving Average | 1,723.96 |
| Relative Strength Index (RSI) | 57.99 |
| Average Volume (20 Days) | 1,248,189 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, NSE:GLENMARK had revenue of INR 159.97 billion and earned 10.10 billion in profits. Earnings per share was 35.78.
| Revenue | 159.97B |
| Gross Profit | 113.72B |
| Operating Income | 36.24B |
| Pretax Income | 15.27B |
| Net Income | 10.10B |
| EBITDA | 39.18B |
| EBIT | 36.24B |
| Earnings Per Share (EPS) | 35.78 |
Balance Sheet
The company has 26.90 billion in cash and 12.24 billion in debt, giving a net cash position of 14.66 billion or 51.95 per share.
| Cash & Cash Equivalents | 26.90B |
| Total Debt | 12.24B |
| Net Cash | 14.66B |
| Net Cash Per Share | 51.95 |
| Equity (Book Value) | 95.82B |
| Book Value Per Share | 339.57 |
| Working Capital | 44.94B |
Cash Flow
In the last 12 months, operating cash flow was 27.92 billion and capital expenditures -10.04 billion, giving a free cash flow of 17.88 billion.
| Operating Cash Flow | 27.92B |
| Capital Expenditures | -10.04B |
| Free Cash Flow | 17.88B |
| FCF Per Share | 63.35 |
Margins
Gross margin is 71.09%, with operating and profit margins of 22.65% and 6.31%.
| Gross Margin | 71.09% |
| Operating Margin | 22.65% |
| Pretax Margin | 9.55% |
| Profit Margin | 6.31% |
| EBITDA Margin | 24.49% |
| EBIT Margin | 22.65% |
| FCF Margin | 11.18% |
Dividends & Yields
This stock pays an annual dividend of 2.50, which amounts to a dividend yield of 0.13%.
| Dividend Per Share | 2.50 |
| Dividend Yield | 0.13% |
| Dividend Growth (YoY) | 100.00% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 6.98% |
| Buyback Yield | -0.02% |
| Shareholder Yield | 0.11% |
| Earnings Yield | 1.84% |
| FCF Yield | 3.26% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on September 10, 2007. It was a forward split with a ratio of 2.
| Last Split Date | Sep 10, 2007 |
| Split Type | Forward |
| Split Ratio | 2 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 7 |